XML 16 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value (Tables)
12 Months Ended
Jul. 26, 2014
Fair Value Disclosures [Abstract]  
Assets And Liabilities Measured At Fair Value On A Recurring Basis
Assets and liabilities measured at fair value on a recurring basis as of July 26, 2014 and July 27, 2013 were as follows (in millions):
 
JULY 26, 2014
FAIR VALUE MEASUREMENTS
 
JULY 27, 2013
FAIR VALUE MEASUREMENTS
 
Level 1
 
Level 2
 
Level 3
 
Total
Balance
 
Level 1
 
Level 2
 
Total
Balance
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
$
4,935

 
$

 
$

 
$
4,935

 
$
6,045

 
$

 
$
6,045

Available-for-sale investments:
 
 
 
 
 
 
 
 
 
 
 
 

U.S. government securities

 
31,734

 

 
31,734

 

 
27,823

 
27,823

U.S. government agency securities

 
1,063

 

 
1,063

 

 
3,089

 
3,089

Non-U.S. government and agency securities

 
861

 

 
861

 

 
1,095

 
1,095

Corporate debt securities

 
9,159

 

 
9,159

 

 
7,881

 
7,881

U.S. agency mortgage-backed securities

 
579

 

 
579

 

 

 

Publicly traded equity securities
1,952

 

 

 
1,952

 
2,797

 

 
2,797

Derivative assets

 
158

 
2

 
160

 

 
182

 
182

Total
$
6,887

 
$
43,554

 
$
2

 
$
50,443

 
$
8,842

 
$
40,070

 
$
48,912

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities
$

 
$
67

 
$

 
$
67

 
$

 
$
171

 
$
171

Total
$

 
$
67

 
$

 
$
67

 
$

 
$
171

 
$
171

Fair Value On A Nonrecurring Basis
The following table presents the Company’s financial instruments and nonfinancial assets that were measured at fair value on a nonrecurring basis during the indicated periods and the related recognized gains and losses for the periods (in millions):
 
 
July 26, 2014
 
July 27, 2013
 
July 28, 2012
 
 
Net Carrying
Value as of
Year End
 
Total Gains (Losses)
for the
Year Ended
 
Net Carrying
Value as of
Year End
 
Total Gains (Losses)
for the
Year Ended
 
Net Carrying
Value as of
Year End
 
Total Gains (Losses)
for the
Year Ended
Assets held for sale
 
$

 
$

 
$
1

 
$
(1
)
 
$
63

 
$
(413
)
Investments in privately held companies (impaired)
 
$
28

 
(21
)
 
$
63

 
(31
)
 
$
47

 
(23
)
Purchased intangible assets
 
$

 

 
$

 

 
$

 
(12
)
Gains (losses) on assets no longer held at end of fiscal year
 
 
 
(2
)
 
 
 
75

 
 
 
14

Total gains (losses) for nonrecurring measurements
 
 
 
$
(23
)
 
 
 
$
43

 
 
 
$
(434
)